Literature DB >> 17159006

The latest and greatest new biomarkers: which ones should we measure for risk prediction in our practice?

James A de Lemos.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 17159006     DOI: 10.1001/archinte.166.22.2428

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  4 in total

1.  B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina.

Authors:  Ricardo León de la Fuente; Patrycja A Naesgaard; Stein Tore Nilsen; Leik Woie; Torbjoern Aarsland; Patricio Gallo; Heidi Grundt; Harry Staines; Dennis W T Nilsen
Journal:  BMC Cardiovasc Disord       Date:  2011-09-29       Impact factor: 2.298

2.  Association of cardiovascular risk using non-linear heart rate variability measures with the framingham risk score in a rural population.

Authors:  Herbert F Jelinek; Hasan Md Imam; Hayder Al-Aubaidy; Ahsan H Khandoker
Journal:  Front Physiol       Date:  2013-07-26       Impact factor: 4.566

3.  B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study.

Authors:  Trygve Brügger-Andersen; Volker Pönitz; Harry Staines; David Pritchard; Heidi Grundt; Dennis W T Nilsen
Journal:  BMC Cardiovasc Disord       Date:  2008-11-25       Impact factor: 2.298

4.  Borderline Values of Troponin-T and High Sensitivity C-Reactive Protein Did Not Predict 2-Year Mortality in TnT Positive Chest-Pain Patients, Whereas Brain Natriuretic Peptide Did.

Authors:  Dennis W T Nilsen; Øistein Rønneberg Mjelva; Ricardo A Leon de la Fuente; Patrycja Naesgaard; Volker Pönitz; Trygve Brügger-Andersen; Heidi Grundt; Harry Staines; Stein Tore Nilsen
Journal:  Front Cardiovasc Med       Date:  2015-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.